Medicenna Therapeutics Corp
(TSX:MDNA)
C$
2.01
-0.02 (-0.99%)
Market Cap: 153.63 Mil
Enterprise Value: 131.87 Mil
PE Ratio: 0
PB Ratio: 7.50
GF Score: 38/100 Medicenna Therapeutics Corp at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 25, 2023 / 07:30PM GMT
Release Date Price:
C$0.9
(+9.76%)
David Martin
Bloom Burton & Co. - Analyst
I think we're ready to go. We're going to switch things up a little bit here. Fahar asked if he could do a fireside chat. We don't have a fire, but if you have a lighter Fahar, we could --
Fahar Merchant
Medicenna Therapeutics Corp. - President & CEO
We could light up the place.
David Martin
Bloom Burton & Co. - Analyst
-- set fire to that.
The interesting thing is the first fireside chat we ever did was last year and that was Bellus, and they just got bought, as Brian said, for $2 billion or so. The task is on you, Fahar. We can cross our fingers and hope and we can produce the data to support a nice acquisition.
Fahar Merchant
Medicenna Therapeutics Corp. - President & CEO
Well, the data will speak for itself.
David Martin
Bloom Burton & Co. - Analyst
Well. I'm sorry, I understand you brought a few slides to start us off. If you can go through
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot